Back to MW Marshall Wace, LLP

VKTXVKTX

Showing 6 of 14 quarters

Position history for MWMarshall Wace, LLP's holdings in Viking Therapeutics, Inc.

Yes. Marshall Wace holds 42,767 shares of VKTX (Viking Therapeutics), worth $1.7M, as of its Q2 2026 13F filing. It reduced the position by 47,593 shares (-52.7%) from Q1 2026. Marshall Wace has held VKTX since Q1 2026, across 2 quarterly 13F filings.

Current Value

$1.7M

Current Shares

42,767

Total Value Change

+$537,750

Total Shares Change

+24,909

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
42,767
-52.7%
$1.7M0.0%$39.01
0
2026-Q1
New
90,360
—
$2.9M0.0%$32.54
36
2025-Q2
Exited
0
-100.0%
$00.0%$26.50
0
2025-Q1
Increased
207,873
+933.5%
$5M0.0%$24.15
43
2024-Q4
Increased
20,114
+12.6%
$809,3870.0%$40.24
28
2024-Q3
Decreased
17,858
-75.8%
$1.1M0.0%$63.31
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used